NKX2-1, encoding a homeobox transcription factor, is amplified in approximately 15% of non-small cell lung cancers (NSCLC), where it is thought to drive cancer cell proliferation and survival. The gene discussed is NKX2-1; the disease is non-small cell lung carcinoma.